Yifei Wang

Dr. Yifei Wang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YWYifei Wang
Yifei Wang
QLQing Li
Qing Li
LBLei Bi
Lei Bi
BWBin Wang
Bin Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
Ischemic heart disease (IHD) remains a leading cause of mortality and morbidity globally. This study aims to evaluate the trends in IHD burden across different socioeconomic regions using data from the Global Burden of Disease Study 2021 (GBD 2021) and to understand the impact of the metabolic risk factors on these trends. Data from GBD 2021 was analyzed to evaluate the global age-standardized death rates (ASDR) and disability-adjusted life years (ASRDALYs) linked to IHD. Key metabolic risk factors evaluated included high systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDLc), fasting plasma glucose (FPG), and body mass index (BMI). Temporal trends were assessed using estimated annual percentage changes (EAPCs), with further analysis by age, sex and socio-demographic index (SDI). Resource-abundant regions showed notable reductions in ASDR and ASRDALYs, largely due to effective management of SBP and LDLc, resulting in an EAPC of -3.43 (95% CI: -3.32, -3.53). In contrast, resource-limited regions, particularly among males, experienced stagnation or even increases in IHD burden. The EAPC of ASDR in low-, low-middle-, and middle-SDI regions ranged from − 0.12 (95% CI: -0.04, -0.19) to 0.16 (95% CI: 0.09, 0.23). Among males, the values ranged from 0.22 (95% CI: 0.14, 0.29) to 0.55 (95% CI: 0.47, 0.62). The increase in IHD burden in these regions was primarily driven by rising levels of FPG and BMI. Younger populations (15–49 years) were disproportionately affected, showing increasing exposure to these metabolic risks. Regional disparities in IHD burden persist, primarily driven by metabolic risk factors. Resource-abundant regions have benefitted from effective control of SBP and LDLc, whereas resource-limited regions face growing challenges, especially related to FPG and BMI. The use of secondary data from the GBD 2021 database provides a comprehensive global perspective but may not fully capture local variations in disease burden. Targeted public health strategies and early interventions are essential to reduce the growing IHD burden in these vulnerable populations.

24 April 2025 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
YWYifei Wang
Yifei Wang
LBLei Bi
Lei Bi
QLQing Li
Qing Li
QWQiuyu Wang
Qiuyu Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
The remnant cholesterol inflammatory index (RCII) is a novel metric that combines remnant cholesterol and high-sensitivity C-reactive protein, reflecting the metabolic and inflammatory risk. This study investigates the association between RCII and long-term risks of all-cause and cause-specific mortality in middle-aged and elderly populations in the US and China. We analyzed data from the National Health and Nutrition Examination Survey (NHANES) and the China Health and Retirement Longitudinal Study (CHARLS), including 7,565 and 12,932 participants aged 45 years and older, respectively. The participants were categorized into quartiles based on natural log-transformed RCII (lnRCII) values. Kaplan–Meier survival analysis, Cox proportional hazards models, restricted cubic splines (RCS) and mediation analysis were used to examine the relationship between lnRCII and mortality outcomes, adjusting for potential covariates. The mean age of the participants was 59.90 ± 10.44 years (NHANES) and 58.64 ± 9.78 years (CHARLS), with 53.28% and 52.50% female, respectively. Kaplan–Meier survival analysis showed that higher lnRCII quartiles (≥ 0.79 in NHANES, ≥ -0.13 in CHARLS) were significantly associated with increased all-cause mortality risk (p < 0.001). Each standard deviation (SD) increase in lnRCII corresponded to a higher risk of all-cause mortality, and the hazard ratios (HRs) and 95% confidence interval (CI) were 1.29 (95% CI: 1.21–1.36) in NHANES and 1.26 (95% CI: 1.15–1.38) in CHARLS. In NHANES, lnRCII was also associated with elevated risks of cardiovascular mortality (HR = 1.21, 95% CI: 1.08–1.35) and cancer mortality (HR = 1.30, 95% CI: 1.09–1.55). RCS analysis indicated a J-shaped relationship between lnRCII and both all-cause and cardiovascular mortality, and a linear association with cancer mortality. Mediation analysis showed that systolic blood pressure and fasting plasma glucose partially mediated these associations. Subgroup analyses suggested a stronger association between lnRCII and all-cause mortality in middle-aged US participants (p for interaction = 0.010). Elevated RCII levels are significantly associated with increased all-cause mortality risk middle-aged and elderly populations in both the US and China. In the US population, RCII is also associated with increased risks of cardiovascular and cancer mortality. By integrating metabolic and inflammatory risk factors, RCII may serve as a valuable tool for mortality risk stratification and clinical decision-making.

29 January 2025 in Tobacco Induced Diseases
Verified
Journal Article
Open access
YWYifei Wang
Yifei Wang
QLQing Li
Qing Li
LBLei Bi
Lei Bi
BWBin Wang
Bin Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
Introduction: Ischemic heart disease (IHD) remains a leading cause of death and disability worldwide. This study evaluates the trends in IHD burden attributable to smoking, utilizing Global Burden of Disease Study 2021 (GBD 2021) data, across 204 countries and territories from 1990 to 2021. By...

23 October 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
TLTingting Lv
Tingting Lv
QLQing Liu
Qing Liu
YWYifei Wang
Yifei Wang
PZPing Zhang
Ping Zhang
Climate change poses a significant threat to cardiovascular health through the combined effects of extreme temperatures, air pollution, and extreme weather events. Short-term heat exposure raises mortality risk by 3.80%, while long-term exposure to particulate matter (PM2.5, with an aerodynamic diameter of ≤2.5 micrometers) increases cardiovascular mortality by 11–20%. Key mechanisms include thermoregulatory stress, inflammation, autonomic nervous system dysfunction, prothrombotic state, and psychosocial stress. Vulnerable groups, such as older individuals and those with cardiovascular diseases, also face a higher risk. Epidemiological studies have shown that for every one-standard-deviation increase in the number of days with excess heat factor, the overall mortality risk rises by 3.80%. Proposed interventions include high-efficiency particulate air (HEPA) purifiers, optimized cooling centers, and low-emission zones. However, key research gaps remain in the effects of multi-stressors, protection strategies, exposure assessment, and climate-driven disease projections. Multidisciplinary collaboration is crucial for mitigating climate-related cardiovascular risks. This review provides a comprehensive overview of the current situation regarding climate change and cardiovascular health, summarizing the results of epidemiological, pathological mechanisms, and policy research.

16 July 2025 in Preventive Medicine
Verified
Journal Article
Open access
YWYifei Wang
Yifei Wang
TDTianshan Dong
Tianshan Dong
BWBin Wang
Bin Wang
PZPing Zhang
Ping Zhang
To investigate the association between Life's Essential 8 (LE8) health behavior component score and mortality outcomes among individuals with Cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3. 8067 U.S. adults from the National Health and Nutrition Examination Survey 2005-2018, aged 30-79 years with CKM syndrome stages 0-3, were analyzed. Mortality status was obtained via linkage to the National Death Index through December 31, 2019. Kaplan-Meier analysis, multivariable Cox regression, and restricted cubic splines (RCS) were used to examine associations between LE8 health behavior component score and mortality outcomes. CKM stages were distributed as follows: 7.8 % (stage 0), 21.0 % (stage 1), 64.0 % (stage 2), and 7.3 % (stage 3). Higher LE8 total score and health behavior component score were linked to reduction in all-cause mortality and cardiovascular mortality risk. RCS analysis showed a linear relationship between LE8 total score, health behavior component score and mortality outcomes. Interaction between health behavior component score and CKM syndrome stages was identified for all-cause mortality. Higher LE8 health behavior component score is associated with reduced all-cause and cardiovascular mortality among population with CKM syndrome stages 0-3. These findings support the potential value of behavior-targeted interventions tailored to CKM syndrome stages.

22 April 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
QLQing Li
Qing Li
YWYifei Wang
Yifei Wang
BWBin Wang
Bin Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
Congenital long QT syndrome (LQTS) is a potentially life-threatening hereditary arrhythmia characterized by a prolonged QT interval on electrocardiogram (ECG) due to delayed ventricular repolarization. This condition predisposes individuals to severe arrhythmic events, including ventricular tachycardia and sudden cardiac death. Traditional approaches to LQTS research and treatment are limited by an incomplete understanding of its gene-specific pathophysiology, variable clinical presentation, and the challenges associated with developing effective, personalized therapies. Recent advances in human induced pluripotent stem cell (iPSC) technology have opened new avenues for elucidating LQTS mechanisms and testing therapeutic strategies. By generating cardiomyocytes from patient-specific iPSCs (iPSC-CMs), it is now possible to recreate the patient’s genetic context and study LQTS in a controlled environment. This comprehensive review describes how iPSC technology deepens our understanding of LQTS and accelerates the development of tailored treatments, as well as ongoing challenges such as incomplete cell maturation and cellular heterogeneity.